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Abstract
Background: Tracheostomy is recommended in case of prolonged mechanical ventilation. Therefore, most patients
with an indication for venovenous extracorporeal membrane oxygenation (ECMO) will also have an indication for
tracheostomy.
Case presentation: We report 2 cases of fatal air embolism into the ECMO system as complication of percutaneous
dilatational tracheostomy. Both patients had an AVALON ELITE® bi-caval cannula implanted draining blood from the
vena cava superior and inferior.
Conclusion: Since there is limited safety data on this specific group of patients, a routine early dilatational
tracheostomy might be associated with a significant risk.
Keywords: ECMO, Extracorporeal membrane oxygenation, Complication, Air embolization, Percutaneous dilatational
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Background
Tracheostomy is recommended in critical ill patients when
prolonged mechanical ventilation is presumed [1]. Optimal
timing of tracheostomy is still under debate [1, 2]. How-
ever, a recently published meta-analysis suggests that per-
forming tracheostomy within 7 days after intubation may
reduce intensive care unit stay [2]. Most studies comparing
early to late tracheostomy defined late tracheostomy as
performed in week two after intubation [1, 2]. Venovenous
extracorporeal membrane oxygenation (vv-ECMO) is a
treatment option for severe adult respiratory failure [3].
The average time on mechanical ventilation of vv-ECMO
patients is 23 days [4]. Therefore most vv-ECMO patients
will have an indication for tracheostomy.
We have to report 2 cases of fatal air embolism into the
vv-ECMO in patients undergoing percutaneous dilata-
tional tracheostomy while being on full ECMO support.
Case 1
A 65 year old male without significant comorbidities
presented at a non-ECMO hospital with H1N1 pneu-
monia. As a severe ARDS developed (Horovitz index
58) a vv-ECMO was implanted via the right jugular
vein using a 31 Fr AVALON ELITE® bi-caval catheter
and the patient was transferred to our intensive care
unit. Six days after ECMO initiation, the patient was
still ECMO dependent (blood flow 3.9 l/min, gas flow
of 5.0 l/min) while on invasive mechanical ventilation
(FiO2 45 %, PEEP 15 mbar). We therefore presumed
a prolonged weaning and aimed for a percutaneous
dilatational tracheostomy using the ULTRAperc sys-
tem (Portex®, Smith medical, England) with broncho-
scopic guidance. After puncture of the trachea and
immediately after the first dilation step a significant
air embolism into the ECMO system was observed.
The ECMO system was halted but air could not be
removed. Invasive mechanical ventilation failed to
achieve sufficient oxygenation and hypoxic cardiac
arrest occurred. After 20 min of cardiopulmonary re-
suscitation the patient could be stabilized after
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implantation of a new ECMO system. Even though pri-
mary resuscitation was successful the patient never recov-
ered from the event and died on ECMO at day 27.
Case 2
A 57-year old male was admitted to hospital for acute
interstitial lung disease. He developed progressive com-
bined hypoxic (Horovitz index 54) and hypercapnic re-
spiratory failure. Venovenous ECMO therapy was
established using a 27 Fr bi-caval catheter (AVALON
ELITE®, Maquet, Germany). A combined immunosup-
pressive therapy with cyclophosphamide and prednisol-
one was initiated. After 10 days of mechanical
ventilation (fiO2 45 %, PEEP 9) and 4 days on vv-ECMO
(blood flow 4.5 l/min, gas flow 7.0 l/min) we performed
dilatational tracheostomy using the 8.0 Fr Ciaglia Blue
Rhino® percutaneous introducer set (Cook medicals,
USA). Stab incision and sequential dilation caused minor
venous bleeding. The dilator was reintroduced and
external compression applied. Within seconds air
embolism into the ECMO system occurred. Rapidly, the
patient developed hypoxemia leading to cardiac arrest.
Despite immediate resuscitation and implantation of a
new ECMO system via the femoral veins return of
spontaneous circulation could not be achieved.
Discussion
Percutaneous dilatational tracheostomy is a frequent
intervention in critical ill patients on the intensive care
unit. In large case series, mortality rates range from
0.17 % [5] to 0.60 % [6]. Most of these fatal complica-
tions however were not directly associated with trache-
ostomy. Case series of fatal complications directly
related to percutaneous dilatational tracheostomy [7]
report damage of large arteries, uncontrollable bleeding
or airway loss. A significant air embolization after surgi-
cal tracheostomy was reported earlier [8] but did not
reach significant levels in a meta-analysis including over
113.000 procedures [6].
In a recent review, 30 out of 168 patients underwent
tracheotomy while on ECMO therapy [4] with a signifi-
cant variation between different centers (ranging from 4
to 46 % of all ECMO patients). No data is available con-
cerning ECMO cannulation (bi-femoral, femo-jugular or
bi-jugular) [4]. A case of a fatal complication directly re-
lated to tracheostomy in ECMO patients has not been
reported so far. Bleeding, the most frequent complica-
tion of tracheostomy [4, 6, 7], however might be even
pronounced in ECMO patients due to activation and
consumption of coagualiton enzymes, platelet depletion
and anticoagulant medication [9].
In the 2 patients presented here, the air embolization
into the ECMO was detected seconds after dilation with
a percutaneous tracheostomy dilator. Both patients were
on full ECMO support via an AVALON ELITE®
(Maquet, Germany) bi-caval dual lumen cannula drain-
ing blood directly from the superior vena cava (Fig. 1).
Especially with higher ECMO blood flow, this might
result in significant negative pressure in the draining
vessels. We therefore hypothesize that suction of air
through the inferior thyroidal vein draining blood dir-
ectly to the vena cava superior might be responsible for
fatal air embolism in both patients.
During the time period between 2013 to 2015, we per-
formed a total of 30 percutaneous dilatational tracheostomy
in patients on ECMO therapy, of which 24 had an Avalon
elite cannula. As a routine measure, an ultrasound study is
performed in all our patients in order to rule out large ves-
sels at the puncture site before proceeding to dilatational
tracheostomy. Since bleeding incidence is comparable in
surgical versus dilatational tracheostomy [1, 10] it appears
Fig. 1 Air embolization into the ECMO system during tracheostomy.
The AVALON ELITE bi-caval cannula drains venous blood from the
superior as well as the inferior vena cava. Since the inferior thyroid
vein directly drains into the vena cava superior, a venous damage
during tracheostomy might result in severe air embolization into
the ECMO
Lother et al. Journal of Cardiothoracic Surgery  (2016) 11:102 Page 2 of 3
unlikely that surgical tracheostomy could have prevented
these complications.
In response to the incidents described above we imple-
mented the following points before performing a trache-
ostomy in ECMO patients on AVALON ELITE®
cannulas.
– In case of severe hypoxia without ECMO (using
100 % FiO2 at the respirator) delay tracheostomy.
– During tracheostomy reduce ECMO blood flow (and
thus negative suction pressure) as far as possible.
– Perform tracheostomy in a head down position.
– Cover puncture site at all times with wet
compresses.
Conclusion
There is limited data on safety of percutaneous dilata-
tional tracheostomy in ECMO patients. Especially in pa-
tients on full ECMO support using the AVALON
ELITE® bi-caval dual lumen catheter dilatational trache-
ostomy might be associated with a significant risk.
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